Schedule 13D ownership disclosure
Millendo Therapeutics, Inc.
Security class unavailable · CUSIP: 60040X103
Event date: 2020-07-23
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 590,105
- Percent of class
- 3.1000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-20-088216
- Form type
- SC 13D
- Filer
- Bpifrance Participations SA
- CIK
- CIK 1581835
- Filed
- Jul 30, 2020
- Reporting period
- Jul 23, 2020
- Description
- Schedule 13D beneficial ownership